The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
A gene expression signature for high-risk multiple myeloma
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Bioconductor: open software development for computational biology and bioinformatics
Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J., et al. (2004) · Genome Biology · doi:10.1186/gb-2004-5-10-r80 · Cited by 12,172
Adjusting batch effects in microarray expression data using empirical Bayes methods
Johnson, W. E., Li, C., & Rabinovic, A. (2007) · Biostatistics · doi:10.1093/biostatistics/kxj037 · Cited by 8,658
A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma
Richardson, P. G., Barlogie, B., Berenson, J., Singhal, S., Jagannath, S., Irwin, D., Rajkumar, S. V., Srkalovic, G., Alsina, M., Alexanian, R., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030288 · Cited by 2,632
Bortezomib or High-Dose Dexamethasone for Relapsed Multiple Myeloma
Richardson, P. G., Sonneveld, P., Schuster, M. W., Irwin, D., Stadtmauer, E. A., Facon, T., Harousseau, J.-L., Ben-Yehuda, D., Lonial, S., Goldschmidt, H., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043445 · Cited by 2,491
Self-citationPalumbo, A., & Anderson, K. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1011442 · Cited by 2,326
Raje, N., & Anderson, K. C. (2000) · Current Treatment Options in Oncology · doi:10.1007/s11864-000-0017-x · Cited by 2,163
The molecular classification of multiple myeloma
Zhan, F., Huang, Y., Colla, S., Stewart, J. P., Hanamura, I., Gupta, S., Epstein, J., Yaccoby, S., Sawyer, J., Burington, B., et al. (2006) · Blood · doi:10.1182/blood-2005-11-013458 · Cited by 1,133
Shaughnessy, J. D., Zhan, F., Burington, B. E., Huang, Y., Colla, S., Hanamura, I., Stewart, J. P., Kordsmeier, B., Randolph, C., Williams, D. R., et al. (2007) · Blood · doi:10.1182/blood-2006-07-038430 · Cited by 914
Prediction by Supervised Principal Components
Bair, E., Hastie, T., Paul, D., & Tibshirani, R. (2006) · Journal of the American Statistical Association · doi:10.1198/016214505000000628 · Cited by 817
A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma
Jagannath, S., Barlogie, B., Berenson, J., Siegel, D., Irwin, D., Richardson, P. G., Niesvizky, R., Alexanian, R., Limentani, S. A., Alsina, M., et al. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05188.x · Cited by 740
Chesi, M., Nardini, E., Brents, L. A., Schröck, E., Ried, T., Kuehl, W. M., & Bergsagel, P. L. (1997) · Nature Genetics · doi:10.1038/ng0797-260 · Cited by 637
Kumar, S. K., Mikhael, J. R., Buadi, F. K., Dingli, D., Dispenzieri, A., Fonseca, R., Gertz, M. A., Greipp, P. R., Hayman, S. R., Kyle, R. A., et al. (2009) · Mayo Clinic Proceedings · doi:10.4065/mcp.2009.0603 · Cited by 628
Molecular Pathogenesis and a Consequent Classification of Multiple Myeloma
Bergsagel, P. L., & Kuehl, W. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.021 · Cited by 556
Mulligan, G., Mitsiades, C., Bryant, B., Zhan, F., Chng, W. J., Roels, S., Koenig, E., Fergus, A., Huang, Y., Richardson, P., et al. (2007) · Blood · doi:10.1182/blood-2006-09-044974 · Cited by 416
Self-citationDecaux, O., Lodé, L., Magrangeas, F., Charbonnel, C., Gouraud, W., Jézéquel, P., Attal, M., Harousseau, J.-L., Moreau, P., Bataille, R., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.8545 · Cited by 371
Broyl, A., Hose, D., Lokhorst, H., de Knegt, Y., Peeters, J., Jauch, A., Bertsch, U., Buijs, A., Stevens-Kroef, M., Beverloo, H. B., et al. (2010) · Blood · doi:10.1182/blood-2009-12-261032 · Cited by 329
Self-citationMunshi, N. C., Anderson, K. C., Bergsagel, P. L., Shaughnessy, J., Palumbo, A., Durie, B., Fonseca, R., Stewart, A. K., Harousseau, J.-L., Dimopoulos, M., et al. (2011) · Blood · doi:10.1182/blood-2010-10-300970 · Cited by 311
Self-citationBarlogie, B., Pineda-Roman, M., van Rhee, F., Haessler, J., Anaissie, E., Hollmig, K., Alsayed, Y., Waheed, S., Petty, N., Epstein, J., et al. (2008) · Blood · doi:10.1182/blood-2008-03-145235 · Cited by 225
Dispenzieri, A., Rajkumar, S. V., Gertz, M. A., Lacy, M. Q., Kyle, R. A., Greipp, P. R., Witzig, T. E., Lust, J. A., Russell, S. J., Hayman, S. R., et al. (2007) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)61029-x · Cited by 223
Hose, D., Reme, T., Hielscher, T., Moreaux, J., Messner, T., Seckinger, A., Benner, A., Shaughnessy, J. D., Barlogie, B., Zhou, Y., et al. (2011) · Haematologica · doi:10.3324/haematol.2010.030296 · Cited by 199
Self-citationShaughnessy, J. D., Qu, P., Usmani, S., Heuck, C. J., Zhang, Q., Zhou, Y., Tian, E., Hanamura, I., van Rhee, F., Anaissie, E., et al. (2011) · Blood · doi:10.1182/blood-2010-12-328252 · Cited by 176
Neben, K., Jauch, A., Bertsch, U., Heiss, C., Hielscher, T., Seckinger, A., Mors, T., Muller, N. Z., Hillengass, J., Raab, M. S., et al. (2010) · Haematologica · doi:10.3324/haematol.2009.016436 · Cited by 173
Self-citationPineda‐Roman, M., Zangari, M., Haessler, J., Anaissie, E., Tricot, G., Van Rhee, F., Crowley, J., Shaughnessy, J. D., & Barlogie, B. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06921.x · Cited by 166
Trudel, S., Ely, S., Farooqi, Y., Affer, M., Robbiani, D. F., Chesi, M., & Bergsagel, P. L. (2004) · Blood · doi:10.1182/blood-2003-10-3650 · Cited by 162
A comparison of oligonucleotide and cDNA-based microarray systems
Mah, N., Thelin, A., Lu, T. T., Nikolaus, S., Kühbacher, T., Gürbüz, Y. S., Eickhoff, H., Klöppel, G., Lehrach, H., Mellgård, B., et al. (2004) · Physiological Genomics · doi:10.1152/physiolgenomics.00080.2003 · Cited by 133
Dickens, N. J., Walker, B. A., Leone, P., Johnson, D. C., Brito, J. L. R., Zeisig, A., Jenner, M. W., Boyd, K. D., Gonzalez, D., Gregory, W. M., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2831 · Cited by 130
Self-citationHideshima, T., Catley, L. P., Raje, N. S., Chauhan, D., Podar, K., Mitsiades, C. S., Tai, Y., Vallet, S., Kiziltepe, T., Ocio, E. M., et al. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06714.x · Cited by 104
Inoue, J., Otsuki, T., Hirasawa, A., et al. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63276-2 · Cited by 99
Sonneveld, P., Schmidt‐Wolf, I. G. H., van der Holt, B., el Jarari, L., Bertsch, U., Salwender, H. J., Zweegman, S., Vellenga, E., Schubert, J. E. A., Blau, I. W., et al. (2010) · Blood · doi:10.1182/blood.v116.21.40.40 · Cited by 88
Self-citationAvet‐Loiseau, H. (2010) · Hematology · doi:10.1182/asheducation-2010.1.489 · Cited by 78
Chng, W. J., Kuehl, W. M., Bergsagel, P. L., & Fonseca, R. (2007) · Leukemia · doi:10.1038/sj.leu.2404934 · Cited by 34
Activation of STAT1 is required for interferon-alpha-mediated cell death
Arulampalam, V., Kolosenko, I., Hjortsberg, L., Björklund, A.-C., Grandér, D., & Tamm, K. P. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.10.002 · Cited by 24
Cited by
The multiple myelomas — current concepts in cytogenetic classification and therapy
Kumar, S. K., & Rajkumar, S. V. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0018-y · Cited by 302
Multiple Myeloma, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology
Kumar, S. K., Callander, N. S., Alsina, M., Atanackovic, D., Biermann, J. S., Chandler, J. C., Costello, C., Faiman, M., Fung, H. C., Gasparetto, C., et al. (2017) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2017.0023 · Cited by 279
Genome-wide somatic alterations in multiple myeloma reveal a superior outcome group
Samur, M. K., Aktas Samur, A., Fulciniti, M., Szalat, R., Han, T., Shammas, M., Richardson, P., Magrangeas, F., Minvielle, S., Corre, J., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.00461 · Cited by 70
Metadata
- Authors
- Kuiper, R., Broyl, A., de Knegt, Y., van Vliet, M. H., van Beers, E. H., van der Holt, B., el Jarari, L., Mulligan, G., Gregory, W., Morgan, G., Goldschmidt, H., Lokhorst, H. M., van Duin, M., & Sonneveld, P.
- Venue
- Leukemia
- Published
- 2012-05-08
- Volume
- 26
- Issue
- 11
- Pages
- 2406-2413
- ISSN
- 0887-6924 (ISSN-L)
- 1476-5551
- OpenAlex
- W2020234719
- Cited by
- 295
- References
- 33
- FWCI
- 10.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.